Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance

Pediatric Infectious Disease Journal

Volumn 31, Issue 4, 2012, Pages 400-403

  Vergison, Anne ^a   Hanquet, Germaine ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE 10; PNEUMOCOCCUS VACCINE 13; PNEUMOCOCCUS VACCINE 7; UNCLASSIFIED DRUG;

DISEASE SURVEILLANCE; EUROPE; HUMAN; INVASIVE PNEUMOCOCCAL DISEASE; KIDNEY DISEASE; LABORATORY TEST; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REVIEW; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

BACTERIOLOGICAL TECHNIQUES; EUROPE; HUMANS; INCIDENCE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 84858773976     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31824bc1f0     Document Type: Review

References (60)

1. Sáez-Llorens X, McCracken GH, Jr. Bacterial meningitis in children. Lancet. 2003;361:2139-48. (Pubitemid 36782263)
2. Jit M. The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis. J Infect. 2010;61:114-24.
3. Rudan I, Boschi-Pinto C, Biloglav Z, et al. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86:408-16. (Pubitemid 351694322)
4. Vergison A, Tuerlinckx D, Verhaegen J, et al.; Belgian Invasive Pneumococcal Disease Study Group. Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough. Pediatrics. 2006;118:e801-9. (Pubitemid 46090009)
5. Kaplan SL, Mason EO Jr., Wald E, et al. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J. 2002;21:141-47. (Pubitemid 34150613)
6. Alpern ER, Alessandrini EA, Bell LM, et al. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics. 2000;106:505-11. (Pubitemid 30664136)
7. Rothrock SG, Green SM, Harper MB, et al. Parenteral vs oral antibiotics in the prevention of serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia: a meta-analysis. Acad Emerg Med. 1998;5:599-606. (Pubitemid 28283657)
8. Whitney CG, Farley MM, Hadler J, et al.; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-46. (Pubitemid 36514704)
9. Huang SS, Hinrichsen VL, Stevenson AE, et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009;124:e1-11.
10. Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep. 2005;54:893-97.
11. Hanquet G, Perrocheau A, Kissling E, et al. Surveillance of invasive pneumococcal disease in 30 EU countries: towards a European system? Vaccine. 2010;28:3920-28.
12. Rodenburg GD, de Greeff SC, Jansen AG, et al. Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands. Emerging Infect Dis. 2010;16:816-23.
13. Lepoutre A, Varon E, Georges S, et al. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill. 2008;13:3.
14. Rückinger S, van der Linden M, Reinert RR, et al. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine. 2009;27:4136-41.
15. Harboe ZB, Valentiner-Branth P, Benfield TL, et al. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Vaccine. 2010;28:2642-7.
16. Hanquet G, Kissling E, Fenoll A, et al. Pneumococcal serotypes in children in 4 European countries. Emerging Infect Dis. 2010;16:1428-39.
17. Dorléans F, Varon E, Lepoutre A, et al. Impact de la vaccination par le vaccin antipneumococcique conjugué heptavalent sur l'incidence des infections invasives à pneumocoques en France. Analyse des données de 2008. INVS, 2011.
18. Vestrheim DF, Løvoll O, Aaberge IS, et al. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine. 2008;26:3277-81.
19. Hanquet G, Lernout T, Vergison A, et al. Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges. Vaccine. 2011;29:2856-64.
20. Hill PC, Cheung YB, Akisanya A, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin Infect Dis. 2008;46:807-14. (Pubitemid 351417179)
21. Syrjänen RK, Kilpi TM, Kaijalainen TH, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. J Infect Dis. 2001;184:451-9. (Pubitemid 32718509)
22. Labout JA, Duijts L, Arends LR, et al. Factors associated with pneumococcal carriage in healthy Dutch infants: the generation R study. J Pediatr. 2008;153:771-6.
23. Torzillo PJ, Hanna JN, Morey F, et al. Invasive pneumococcal disease in central Australia. Med J Aust. 1995;162:182-6.
24. O'Brien KL, Shaw J, Weatherholtz R, et al. Epidemiology of invasive Streptococcus pneumoniae among Navajo children in the era before use of conjugate pneumococcal vaccines, 1989-1996. Am J Epidemiol. 2004;160:270-78. (Pubitemid 39006783)
25. Nuorti JP, Butler JC, Gelling L, et al. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med. 2000;132:182-90. (Pubitemid 30064917)
26. Hanage WP, Kaijalainen TH, Syrjänen RK, et al. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun. 2005;73:431-5. (Pubitemid 40041136)
27. Brueggemann AB, Peto TE, Crook DW, et al. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis. 2004;190:1203-11. (Pubitemid 39287745)
28. Sandgren A, Sjostrom K, Olsson-Liljequist B, et al. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis. 2004;189:785-96. (Pubitemid 38328178)
29. Harboe ZB, Thomsen RW, Riis A, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med. 2009;6:e1000081.
30. Rückinger S, von Kries R, Siedler A, et al. Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome. Pediatr Infect Dis J. 2009;28:118-22.
31. Kalin M. Pneumococcal serotypes and their clinical relevance. Thorax. 1998;53:159-62. (Pubitemid 28172363)
32. Saha SK, Naheed A, El Arifeen S, et al. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution. Clin Infect Dis. 2009;48(suppl 2):S75-81.
33. Harboe ZB, Benfield TL, Valentiner-Branth P, et al. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis. 2010;50:329-37.
34. Hausdorff WP. The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease. Vaccine. 2007;25:2406-12. (Pubitemid 46366120)
35. Hausdorff WP, Bryant J, Paradiso PR, et al. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000;30:100-21. (Pubitemid 30067069)
36. Miller E, Andrews NJ, Waight PA, et al. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis. 2011;11:760-8.
37. Guillemot D, Varon E, Bernède C, et al. Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin Infect Dis. 2005;41:930-8. (Pubitemid 41368213)
38. Muñoz-Almagro C, Esteva C, de Sevilla MF, et al. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona. J Infect. 2009;59:75-82.
39. Baraff LJ. Management of fever without source in infants and children. Ann Emerg Med. 2000;36:602-14.
40. Ihekweazu CA, Dance DA, Pebody R, et al. Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005. Epidemiol Infect. 2008;136:1096-102. (Pubitemid 351982931)
41. Pérez A, Herranz M, Segura M, et al. Epidemiologic impact of blood culture practices and antibiotic consumption on pneumococcal bacteraemia in children. Eur J Clin Microbiol Infect Dis. 2008;27:717-24.
42. Dalton HP, Allison MJ. Modification of laboratory results by partial treatment of bacterial meningitis. Am J Clin Pathol. 1968;49:410-3.
43. Resti M, Micheli A, Moriondo M, et al. Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: a prospective, observational study of children and adolescents with proven pneumococcal infection. Clin Ther. 2009;31:1266-73.
44. Connell TG, Rele M, Cowley D, et al. How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics. 2007;119:891-96. (Pubitemid 46715658)
45. Ramirez M, Melo-Cristino J. Expanding the diagnosis of pediatric bacteremic pneumococcal pneumonia from blood cultures to molecular methods: advantages and caveats. Clin Infect Dis. 2010;51:1050-2.
46. Neuman MI, Harper MB. Evaluation of a rapid urine antigen assay for the detection of invasive pneumococcal disease in children. Pediatrics. 2003;112(6 Pt 1):1279-82. (Pubitemid 37523407)
47. Dowell SF, Garman RL, Liu G, et al. Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients. Clin Infect Dis. 2001;32:824-5. (Pubitemid 32221944)
48. Charkaluk ML, Kalach N, Mvogo H, et al. Assessment of a rapid urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal infection in children. Diagn Microbiol Infect Dis. 2006;55:89-94. (Pubitemid 43792404)
49. Martinon-Torres F, Dosil-Gallardo S, Perez Del Molino-Bernal ML, et al. Pleural antigen assay in the diagnosis of pediatric pneumococcal empyema [published online ahead of print July 5, 2011]. J Crit Care. doi: 10.1016/j.jcrc.2011.05.004.
50. Resti M, Moriondo M, Cortimiglia M, et al.; Italian Group for the Study of Invasive Pneumococcal Disease. Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis. 2010;51:1042-9.
51. Dagan R, Shriker O, Hazan I, et al. Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR. J Clin Microbiol. 1998;36:669-73. (Pubitemid 28093247)
52. Isaacman DJ, Zhang Y, Reynolds EA, et al. Accuracy of a polymerase chain reaction-based assay for detection of pneumococcal bacteremia in children. Pediatrics. 1998;101:813-6. (Pubitemid 28204829)
53. Huong Thi Thu Vu M, Lay Myint Yoshida, Motoi Suzuki, et al. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis. 2011;30:8.
54. Korppi M, Leinonen M, Ruuskanen O. Pneumococcal serology in children's respiratory infections. Eur J Clin Microbiol Infect Dis. 2008;27:167-75.
55. D'Ancona F, Salmaso S, Barale A, et al.; Italian PNC-Euro working group. Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine. 2005;23:2494-500.
56. Harboe ZB, Valentiner-Branth P, Benfield TL, et al. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005. Vaccine. 2008;26:3765-71.
57. Pilishvili T, Lexau C, Farley MM, et al.; Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201:32-41.
58. Fitzgerald M, Murchan S, O'Lorcain P, et al. Burden of invasive pneumococcal disease declines since introduction of vaccine. Epi-Insight. 2010;11:1-3.
59. Siegrist C-A. Actualités vaccinologiques suisses: nouveaux vaccins glycoconjugués contre pneumocoques et méningocoques. Rev Med Suisse. 2010;7:154-58.
60. Ruckinger S, von Kries R, Reinert RR, et al. Further incidence trends of invasive pneumococcal disease more than 2 years after introduction of 7-valent pneumococcal conjugate vaccination in Germany. ESPID; May 4-8, 2010; Nice, France, 2010.